- Home
- IAG vs RGC Comparison
IAG vs RGC Comparison
Compare IAG & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAG
- RGC
- Stock Information
- Founded
- IAG 1990
- RGC 2014
- Country
- IAG Canada
- RGC Hong Kong
- Employees
- IAG N/A
- RGC N/A
- Industry
- IAG Precious Metals
- RGC Medicinal Chemicals and Botanical Products
- Sector
- IAG Basic Materials
- RGC Health Care
- Exchange
- IAG Nasdaq
- RGC Nasdaq
- Market Cap
- IAG 7.9B
- RGC 8.4B
- IPO Year
- IAG 1996
- RGC 2021
- Fundamental
- Price
- IAG $15.52
- RGC $11.91
- Analyst Decision
- IAG Buy
- RGC
- Analyst Count
- IAG 4
- RGC 0
- Target Price
- IAG $15.25
- RGC N/A
- AVG Volume (30 Days)
- IAG 10.0M
- RGC 129.1K
- Earning Date
- IAG 11-04-2025
- RGC 10-24-2025
- Dividend Yield
- IAG N/A
- RGC N/A
- EPS Growth
- IAG N/A
- RGC N/A
- EPS
- IAG 0.59
- RGC N/A
- Revenue
- IAG $2,234,600,000.00
- RGC N/A
- Revenue This Year
- IAG $59.71
- RGC N/A
- Revenue Next Year
- IAG $24.62
- RGC N/A
- P/E Ratio
- IAG $26.39
- RGC N/A
- Revenue Growth
- IAG 52.98
- RGC N/A
- 52 Week Low
- IAG $4.98
- RGC $0.09
- 52 Week High
- IAG $15.60
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- IAG 68.98
- RGC 37.92
- Support Level
- IAG $12.63
- RGC $10.33
- Resistance Level
- IAG $14.23
- RGC $13.14
- Average True Range (ATR)
- IAG 0.80
- RGC 1.03
- MACD
- IAG 0.21
- RGC -0.08
- Stochastic Oscillator
- IAG 96.97
- RGC 32.82
About IAG Iamgold Corporation
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.